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Purpose/Objective: To investigate the impact of surgery, 
oncoplastic surgery versus lumpectomy, on the volume of 
tumor bed delineation in irradiated breast cancer (BC) 
patients. 
Materials and Methods: A consecutive series of 293 BC 
patients were treated with breast conserving surgery 
followed by radiotherapy. Of this series, 44 patients 
underwent an oncoplastic procedure and were included in 
this study. The control group consisted of 67 patients who 
underwent a lumpectomy. The controls were matched for 
location (lateral upper quadrant versus other) and tumor to 
breast ratio (small versus large). For the small tumor to 
breast ratio group we included 2 controls for each 
oncoplastic patient. For the group with large tumor to breast 
ratios we included all available patients (1 to 1). The tumor 
bed was delineated based on the presence of the surgical 
clips, hematoma, seroma and/or other surgery-induced 
changes and interpretation of radiology, pathology and 
surgical reports. The association between surgery 
(oncoplastic surgery versus lumpectomy) and delineated 
tumor bed volumes in cm3 was assessed with linear regression 
analyses. Here we present the crude association (using 
univariable analysis) and the association corrected for 
confounding factors (using multivariable analysis). Only 
confounders that changed the association more than 10% 
were included. In these analyses the outcome delineated 
tumor bed volume was log-transformed, the estimated beta’s 
represent the change in log tumor bed volume.  
Results: The oncoplastic operated patients had a radiological 
larger median tumor diameter (21 mm versus 14 mm) than 
the lumpectomy patients. The volume of the pathological 
specimen was not significantly different between the two 
groups: 148.8 cm3 in the oncoplastic group and 135.0 cm3 in 
the lumpectomy group. The median delineated tumor bed 
volume was significantly larger after oncoplastic surgery 
compared to lumpectomy alone (26.3 cm3 vs. 16.4 cm3, 
p<0.001). In the univariable analysis the delineated tumor 
bed volume was 1.7 (β = 0.547, 95% CI 0.297-0.797) times 
larger in patients with an oncoplastic procedure than in the 
patients who underwent a lumpectomy only. After correcting 
for confounders (presence of postoperative seroma and 
radiological tumor diameter (mm)) the delineated tumor bed 
volume after the oncoplastic procedure was 1.9 (β = 0.616, 
95% CI 0.353-0.879) times larger than after a lumpectomy 
only. 
Conclusions: Oncoplastic surgery in breast conserving 
treatment for breast cancer results in larger tumor bed 
volumes for radiotherapy. 
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Purpose/Objective: Neoadjuvant radiochemotherapy (NRT-
CHX) is an innovative technique for the treatment of patients 
with locally advanced non inflammatory breast cancer 
(LABC). The aim of this study was to analyze the long term 
cosmetic outcome in breast conserving and mastectomy 
patients after NRT-CHX. 
Materials and Methods: In a time period from 1991 to 1998 a 
total of 315 LABC patients (cT1-cT4/cN0-N1) were treated 
with NRT-CHX. 160 patients received breast conserving 
surgery (BCS) and 154 patients mastectomy. One patient had 
no surgery. Preoperative radiotherapy (RT) consisted of 
external beam radiation therapy (EBRT) of 50 Gy (5 × 2 
Gy/week) to the breast and the supra-/infraclavicular lymph 
nodes (n=255) combined with a consecutive electron boost in 
214 cases or - a 10-Gy interstitial boost with (192)Ir 
afterloading before EBRT in n=101 cases. Chemotherapy with 
CMF and AC/EC was administered prior to RT in 192 patients, 
and Mitoxantrone concomitantly in n=113 patients; 10 
patients received no chemotherapy. The cosmetic outcome 
was assessed by patient questionnaire in 2013. A panel with 5 
independent investigators evaluated the cosmetic outcome in 
4 grades (excellent, good, moderate and bad). The breast 
retraction assessment (BRA) was quantified by van Limbergen 
Score. Quality-of-life was measured by EORTC QLQ-C30 and 
BR23 and late radiation side effects by LENT/SOMA scale. 
Results: In 64 patients after breast conserving surgery and 43 
patients after mastectomy a long term follow up of the 
cosmetic outcome was possible. Most patients rated their 
overall cosmetics as 'excellent' or 'good' (94% in the breast 
conserving group and 55.8% of the mastectomy group). The 
results for the mastectomy group is in detail: excellent: 
27.91%, good: 27.91%, moderate: 39.53% and bad 4.65%. 
After a follow up of 16-22 years we did not detect any grade 
III or IV late side effects in both groups. The median BRA 
score after breast conserving surgery was 2.9 and the over-all 
quality of life (QLQ-C30) was rated 'excellent' or good in 82%. 
Conclusions: NRT-CHX is associated with an acceptable 
radiotherapeutic toxicity and a good cosmetic outcome. 
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Purpose/Objective: Left sided breast cancer poses a 
significant challenge in sparing the heart and specifically the 
left descending coronary vessels (LCV). Often, a compromise 
between PTV coverage and OAR sparing must be made. Lung 
Gating is seen as a useful method to maximize both. 
However, it is always associated with increased complexity, 
cost and time. We prospectively evaluated the cost-benefit 
of a modern system implemented in a busy community 
hospital environment.  
Materials and Methods: A lung gating system based on the 
breath-hold technique (SDX, QFix, Avondale PN, USA)  
3rd ESTRO Forum 2015                                                                                                                                         S337 
 
 
 
was evaluated on a consecutive series of patients with left 
sided breast cancer. Breath hold training and the acquisition 
of an inspiratory (IN) and expiratory (EX) planning dataset 
were the basis for deciding which patients would be eligible 
for gated irradiation. After contouring of PTV, left lung, 
heart and LCV in the IN dataset, the structures were copied 
to the EX dataset and adapted nonrigidly. Treatment 
planning was performed in identical manner for both datasets 
(IMRT via mainly 2 tangential fields with up to 16 segments), 
allowing optimal comparison between IN- and EX plans. We 
also report the positioning deviations in the A-P direction 
derived from the weekly portal images. 
Results: Of the initial 26 consecutive patients, 25 could be 
CT-planned with the system resulting in 2 datasets each ( IN 
and EX). Of these, 14 (56%) were initially selected for 
treatment in inspiration due to a significant difference in one 
or more OAR. Lung gating had to be discontinued in two 
patients after 3 and 2 fractions respectively due to breath-
hold difficulties which had not been apparent during the 
training session. In patients initially selected for lung gating, 
the maximum (D02) and median (D50) doses to the LCV were 
9.5(range 2.5-48.4) Gy and 3.1(1.8-25.1) Gy, respectively, 
and were significantly lower than those derived from the EX 
plans (p<0.001). The corresponding doses for the patients not 
selected for lung gating were 35.5 (7.3-57.2) Gy and 7.0 (3.1-
39.7) Gy for D02 and D50, respectively, which was not 
significantly different from their IN plan values. Better LCV 
sparing in lung gated patients was not due to compromising 
PTV coverage: The volume of the PTV covered with 95% of 
prescribed dose was 90(73-97)% and 89(83-97)% for lung gated 
and non-lung gated patients, respectively (p=0.90).Median 
treatment times were 478±63s seconds for the lung-gated 
patients vs. 278±37s seconds for the patients treated 
without. The average A-P deviation (n=121) was 2.1 mm. 
Conclusions: These results represent the very first patients 
treated at our institution with this system. Lung-gating 
prolonged treatment time surprisingly little by approximately 
3 minutes per fraction and offered significant benefits on 
OAR sparing to 50 % of the patients. Thorax-excursion 
reproducibility is highly accurate with this system. As a 
limitation, it is only suitable for patients who are able to 
understand both the spoken and visual commands and are 
fully compliant. 
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Purpose/Objective: To compare two automated systems of 
cosmesis and skin evaluation, based on a computer assisted 
photographic assesment and a multiprobe skin tester in 
patients with breast cancer after conservative surgery and 
hypofractionated irradiation. 
Materials and Methods: 50 women with early stage breast 
carcinoma treated with conservative surgery and receiving 
whole breast irradiation and a boost were evaluated. 
Irradiation consisted in 15 whole breast fractions of 2.7 Gy 
followed by a boost to the tumor bed in 6 fractions. The 
minimal follow-up was 2 years. Patient cosmesis evaluation 
by means a validated scale was took as a reference for 
comparisons. Physician evaluation of cosmesis and skin 
toxicity was performed according Harvard scale an RTOG 
scoring criteria respectively. Patient and physician 
evaluations were compared with computerized photographic 
assessment employing a dedicated software (BCCT.Core 2.0) 
and also the analisys of hydration, elasticity and skin 
pigmentation performed by means a multiprobe skin tester 
(Multi Skin Test Center® MC750). 
Results: The most important correlation was obtained with 
computerized assisted photographic assessment and the self 
assessed patient cosmesis scoring. It has been detected that 
the best morphologic values for asymmetry in accordance to 
the patient perception of breast deformity were the BCE 
(Breast Compliance Evaluation) (p=0,018), pBRA (proportional 
Breast Retraction Assesment) (p=0,021) and pUNR 
(proportionalUpward Nipple Retraction) (p=0,023) obtained 
by the software analisys. Also a good association was 
demonstrated between the values of the chronic toxicity and 
the overall evaluation of cosmesis by means the photographic 
software (p=0,041). The multiprobe skin testing 
demonstrated differences both in pigmentation and elasticity 
in the boost area compared with the ipsilateral breast 
(p=0,011 and p=0,003 respectively) and of major magnitude 
when compared to the contralateral breast (p=0,001 and 
p=0,001 respectively). A correlation was found among the 
loss of elasticity of the boost with the patient cosmesis 
evaluation (p=0,055). Physician cosmesis evaluation was 
correlated with breast hydration loss measured by the skin 
tester probe (p=0,015). 
Conclusions: The overall cosmesis seems to be better 
evaluated by software compared to the subjective clinical 
physician evaluations. Nevertheless, the multi-probe skin 
tester device is capable to detect minor changes in elasticity 
and hydration that also correlate with patient and physician 
cosmesis evaluations respectively. 
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